Paul Tudor Jones’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Paul Tudor Jones’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-155,671	Closed	-$20.5M	–	1987
2020 Q4	$20.5M	Buy	+155,671	New	+$13.8M	0.58%	19
2018 Q3	–	Sell	-10,000	Closed	-$203K	–	1337
2018 Q2	$203K	Buy	+10,000	New	+$210K	0.01%	923

Paul Tudor Jones's EIDX Position: Q1 2021 in Review

Paul Tudor Jones sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 155,671 shares — an estimated $20.5M sold.

Paul Tudor Jones first reported a position in EIDX in Q2 2018 and held it in 2 quarters. The position peaked at $20.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Paul Tudor Jones reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Paul Tudor Jones sold 155,671 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $20.5M.
Paul Tudor Jones first reported a position in Eidos Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Paul Tudor Jones's Eidos Therapeutics, Inc. Common Stock position peaked at $20.5M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.